Search - tctmd.com

Displaying 541 - 560 of 647

Sort: Relevancy | Date

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Renal Denervation Systems Show Persistent Reductions in BP

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

Presenter: Stephen Worthley

October 29, 2013

Presentation TCT 2013

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

Presenter: Edith Lubos

October 29, 2013

Presentation TCT 2013

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

Presenter: Stefan Verheye

October 29, 2013

Presentation TCT 2013

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

Presenter: Petr Neuzil

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

News Conference News TCT 2013

BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography

October 29, 2013

Presentation TCT 2013

Stenting of the Renal Artery: Avoiding and Treating Complications

Presenter: Michel Henry

October 28, 2013

Presentation TCT 2013

Renal Denervation: Potential in Treating Heart Failure

Presenter: Erwin Blessing

October 28, 2013

Presentation TCT 2013

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Presenter: Richard Heuser

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Non-Renal Targets for Sympathetic Modification

Presenter: Paul Sobotka

October 28, 2013

Presentation TCT 2013

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Presenter: Satya Reddy Atmakuri

October 28, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

Advertisement

TCT Leadership Outlines the State of Intervention

Renal Denervation Systems Show Persistent Reductions in BP

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

Innovation in Intervention: Perspectives from Industry

TCT-59. Longer term safety and efficacy of sympathetic renal artery denervation using a multi-electrode renal artery denervation catheter in patients with drug-resistant...

TCT-91. MitraClip-Induced Acute Changes in Renal Function Impact Mortality in Surgical High-Risk Patients with Significant Mitral Regurgitation

TCT-62. Preliminary Result of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the Maya Medical OneShot™ Ablation System (RAPID) Study.

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

BOSS: Sodium Bicarbonate May Protect Heart After Coronary Angiography

Stenting of the Renal Artery: Avoiding and Treating Complications

Renal Denervation: Potential in Treating Heart Failure

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Renal Denervation: Ready for Primetime?

REDUCE-HTN: 6-Month Results from a Prospective Registry Study of Renal Denervation Using a Novel Percutaneous Bipolar Radiofrequency Balloon Catheter in Patients With Resistant...

Non-Renal Targets for Sympathetic Modification

EnligHTN 1: 18-Month Results from a Prospective Registry Study of Renal Denervation in Patients with Resistant Hypertension

Endovascular Interventions: Lower Extremity, Aorta, Renal and Carotid Disease

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content